Home › AstraZeneca plc (AZN) Earns "Outperform" Rating from BNP Paribas
 

Keywords :   


AstraZeneca plc (AZN) Earns "Outperform" Rating from BNP Paribas

2015-11-30 21:21:56| Biotech - Topix.net

's stock had its "outperform" rating reaffirmed by research analysts at BNP Paribas in a research note issued to investors on Monday, AnalystRatings.NET reports. AstraZeneca plc traded up 0.09% during trading on Monday, reaching $34.08.

Tags: rating plc earns bnp

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11NI rise hits workers harder than employers, says OBR
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 8
05.11Tropical Storm Rafael Public Advisory Number 8
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 8
05.11Lenzing Expands Nonwovens Range
05.11Netflix Europe offices raided in tax fraud probe
More »